FR215F - Nouveaux médicaments hypoglycémiants. - Google Patents

Nouveaux médicaments hypoglycémiants.

Info

Publication number
FR215F
FR215F FR844F FR215DF FR215F FR 215 F FR215 F FR 215F FR 844 F FR844 F FR 844F FR 215D F FR215D F FR 215DF FR 215 F FR215 F FR 215F
Authority
FR
France
Prior art keywords
hypoglycemic drugs
new hypoglycemic
new
drugs
hypoglycemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR844F
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S IND S O R I SOC D
Original Assignee
RECH S IND S O R I SOC D
Publication of FR215F publication Critical patent/FR215F/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR844F Nouveaux médicaments hypoglycémiants. Active FR215F (fr)

Publications (1)

Publication Number Publication Date
FR215F true FR215F (fr)

Family

ID=1341746

Family Applications (1)

Application Number Title Priority Date Filing Date
FR844F Active FR215F (fr) Nouveaux médicaments hypoglycémiants.

Country Status (1)

Country Link
FR (1) FR215F (fr)

Similar Documents

Publication Publication Date Title
FR215F (fr) Nouveaux médicaments hypoglycémiants.
Rea Hiddenness and transcendence
Mullard Biotechs step on cGAS for autoimmune diseases
Boissier et al. In vitro activities of trioxaquines against Schistosoma mansoni
Kim et al. Total synthesis of pactalactam, an imidazolidinone-type pactamycin analogue
Southwood et al. Host-pathogen interactions
Bhan et al. Investigation of extracellular matrix protein expression dynamics using murine models of systemic inflammation
Comer et al. Utilizing diversity-oriented synthesis in antimicrobial drug discovery
NL176837B (nl) Inhaleerinrichting.
NL161228B (nl) Schroefrotorstelsel.
Havea et al. Reading Ecclesiastes from Asia and Pasifika
NL158379B (nl) Osteotoom.
Sanaullah et al. An Efficient Data Structure and Algorithm for Long-Match Query in Run-Length Compressed BWT
Fei Toluenesulfonyl Cyanide (TsCN)
McNeil The Mimetic Sacred
NL173012C (nl) Kaasvat.
CH4044A (fr) Pompe centrifuge perfectionnée
EP4473986A4 (fr) Pompe à perfusion
Chua et al. Community diagnosis report on Barangay Paliparan East 2, Dasmariñas, Cavite
Costabel et al. Sciences de la Renaissance
FR340982A (fr) Pompe à pistons plongeurs perfectionnée
Barua et al. Symposium:› What limits ought democratic pluralism impose on diversity within a cross-cultural context?
channels Modulating Unlocking the potential of ion channel biologics
NL143156B (nl) Strenggietvorm.
Янушевич et al. Nietzscheanism and problems of modern morality